參考文獻 |
[1] Tra, V. N.; Dube, D. H. “Glycans in pathogenic bacteria – potential for targeted covalent therapeutics and imaging agents” Chem. Commun. 2014, 50, 4659–4673.
[2] Steward, K. “Gram positive vs Gram negative” 2019年8月21日。取自: https://www.technologynetworks.com/immunology/articles/gram-positive-vs-gram-negative-323007。
[3] 王永志,郭書辰,「對抗格蘭氏陰性菌之抗生素新藥簡介」,感染控制雜誌,第28卷第2期,88-96頁,107年4月。
[4] 朱麗鈴,陳麗芳,「多重抗藥性鮑氏不動桿菌之藥物治療策略」,藥學雜誌,第28卷第2期,40-45頁,98年6月。
[5] 吳杰亮等編著,台灣肺炎診治指引,台灣感染症醫學會,台灣胸腔暨重症加護醫學會,財團法人鄭德齡醫學發展基金會,107年10月。
[6] 王修含:抗生素藥理學機轉簡介。99年。取自:
http://www.skin168.net/2013/12/antibiotics.html
[7] Mansy, W.; Muzaheed; Rathod, S. “Temporal association between antibiotic use and resistance in Gram-negative bacteria” Arch. Pharma. Pract. 2020, 11, 13‒18.
[8] 陳偉智,謝永宏,「藉由 Cephalosporins 結構瞭解其各代在臨床使用上的抗菌範圍」,藥學雜誌,第28卷第1期,25‒31頁,101年3月。
[9] Zhanel G. G.; Ennis K.; Vercaigne L.; Walkty A.; Gin A. S.; Embil J.; Smith H.; Hoban D. J. “A critical review of the fluoro-quinolones” Drugs 2002, 62, 13–59.
[10] Lee, I.-M.; Yang, F.-L.; Chen, T.-L.; Liao, K.-S.; Ren, C.-T.; Lin, N.-T.; Chang, Y.-P.; Wu, C.-Y.; Wu, S.-H. “Pseudaminic acid on exopolysaccharide of acinetobacter baumannii plays a critical role in phage-assisted preparation of glycoconjugate vaccine with high antigenicity” J. Am. Chem. Soc. 2018, 140, 8639−8643.
[11] Pradhan, K.; Kulkarni, S. S. “Synthesis of nonulosonic acids” Eur. J. Org. Chem. 2020, DOI: 10.1002/ejoc.202000250.
[12] Chen, X.; Varki, A. “Advances in the biology and chemistry of sialic acids” ACS Chem. Biol. 2010, 5, 163–176.
[13] Knirel, Y. A. “Polysaccharide antigens of Pseudomonas Aeruginosa” Crit. Rev. Microbiol. 1990, 17, 273‒304.
[14] Kenyon, J. J.; Marzaioli, A. M.; Castro, C. D.; Hall, R. M. “5,7-di-N-acetyl-acinetaminic acid: A novel non-2-ulosonic acid found in the capsule of an Acinetobacter baumannii isolate” Glycobiology 2015, 25, 644–654.
[15] Wei, R.; Liu, H.; Li, X. “De novo synthesis of novel bacterial monosaccharide fusaminic acid” J. Antibiot. 2019, 72, 420–431.
[16] Zunk, M.; Kiefel, M. J. “The occurrence and biological significance of the α-keto-sugars pseudaminic acid and legionaminic acid within pathogenic bacteria” RSC Adv. 2014, 4, 3413–3421.
[17] Santra, A.; Xiao, A.; Yu, H.; Li, W.; Li, Y.; Ngo, L.; McArthur, J. B.; Chen, X. “A diazido mannose analogue as a chemoenzymatic synthon for synthesizing di-N-acetyllegionaminic acid-containing glycosides” Angew. Chem. Int. Ed. 2018, 130, 2979–2983.
[18] Tsvetkov, Y. E.; Shashkov, A. S.; Knirel, Y. A.; Zähringer, U. “Synthesis and NMR spectroscopy of nine stereoisomeric 5,7-diacetamido-3,5,7,9-tetradeoxynon-2-ulosonic acids” Carbohydrate Res. 2001, 335, 221–243.
[19] Lee, Y. J.; Kubota, A.; Ishiwata, A.; Ito, Y. “Synthesis of pseudaminic acid, a unique nonulopyranoside derived from pathogenic bacteria through 6-deoxy-AltdiNAc” Tetrahedron Lett. 2011, 52, 418–421.
[20] Williams, J. T.; Corcilius, L.; Kiefel, M. J.; Payne, R. J. “Total synthesis of native 5,7-diacetylpseudaminic acid from N‑acetylneuraminic acid” J. Org. Chem. 2016, 81, 2607−2611.
[21] Liu, H.; Zhang, Y.; Wei, R.; Andolina, G.; Li, X. “Total synthesis of Pseudomonas aeruginosa 1244 pilin glycan via de novo synthesis of pseudaminic acid” J. Am. Chem. Soc. 2017, 139, 13420−13428.
[22] Dhakal, B.; Crich, D. “Synthesis and stereocontrolled equatorially selective glycosylation reactions of a pseudaminic acid donor: Importance of the side chain conformation and regioselective reduction of azide protecting groups” J. Am. Chem. Soc. 2018, 140, 15008−15015.
[23] Pfistera, H. B.; Paolettia, J.; Povedad, A.; Jimenez-Barberod, J.; Mulard, L. A. “Zwitterionic polysaccharides of shigella sonnei: Synthetic study toward a ready-for-oligomerization building block made of two rare amino sugars” Synthesis 2018, 50, 4270−4282.
[24] Nagorny, P.; Fasching, B.; Li, X.; Chen, G.; Aussedat, B.; Danishefsky, S. J. “Toward fully synthetic homogeneous β-human ollicle-stimulating hormone (β-hFSH) with a biantennary N-linked dodecasaccharide. synthesis of β-hFSH with chitobiose units at the natural linkage sites” J. Am. Chem. Soc. 2009, 131, 5792–5799.
[25] Minuth, T.; Irmak, M.; Groschner, A.; Lehnert, T.; Boysen, M. M. K. “Sweets for catalysis -facile optimisation of carbohydrate-based bis(oxazoline) ligands” Eur. J. Org. Chem. 2009, 997–1008.
[26] Chida, N.; Sugihara, K.; Amano, S.; Ogawa, S. “Chiral and stereoselective total synthesis of (‒)-mesembranol starting from D-glucose” J. Chem. Soc., Perkin Trans. 1 1997, 275‒280.
[27] Jenkins, D. J.; Dubreuil, D.; Potter, B. V. L. “Synthesis of D-2-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate from D-glucose” J. Chem. Soc., Perkin Trans. 1 1996, 1365‒1372.
[28] Nash, R. J.; Fleet, G. W. J.; Van Ameijde, J.; Horne, G. “Synthesis of polyhydroxylated alkaloids” PCT Int. Appl. Publication date 26 Jan 2006, publication no WO 2006/008493 A1
[29] Crawford, T. C. “Ascorbic acid synthesis” United States Patent, Patent No. 4111958,
[30] Chen, X.; Xu, P.; Xu, Y.; Liu, L.; Liu, Y.; Zhu, D.; Lei, P. “Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides” Bioorg. Med. Chem. Lett. 2012, 22, 7402–7405.
[31] Zunk, M.; Kiefel, M. J. “An efficient synthesis of selectively functionalized D-rhamnose derivatives” Tetrahedron Lett. 2011, 52, 1296–1299.
[32] Masuda, Y.; Tsuda, H.; Murakami, M. “C1 oxidation/C2 reduction isomerization of unprotected aldoses induced by light/ketone” Angew. Chem. Int. Ed. 2020, 59, 2755–2759.
[33] Kasahara, K.; Iida, H.; Kibayashi, C. “Asymmetric total synthesis of (+)-negamycin and (‒)-3-epinegamycin via enantioselective 1,3-dipolar cycloaddition” J. Org. Chem. 1989, 54, 2225–2233.
[34] Michigami, K.; Terauchi, M.; Hayashi, M. “Cleavage of 4,6-O-benzylidene acetal using sodium hydrogen sulfate monohydrate” Synthesis 2013, 45,1519–1523. |